Last Updated on October 14, 2024 by The Health Master
ICDRA
The 19th International Conference of Drug Regulatory Authorities (ICDRA) inaugurated by Jagat Prakash Nadda, Union Minister of Health and Family Welfare.
The event is being hosted in India for the first time, from October 14-18, 2024 by the Central Drugs Standard Control Organization (CDSCO), Ministry of Health and Family Welfare, in collaboration with the World Health Organization (WHO).
India Hosts the 19th ICDRA: A Global Gathering of Drug Regulatory Authorities
India made history as it hosted the 19th International Conference of Drug Regulatory Authorities (ICDRA) from October 14-18, 2024.
This prestigious event, organized by the Central Drugs Standard Control Organization (CDSCO) in collaboration with the World Health Organization (WHO), brought together regulatory experts, policymakers, and health officials from over 194 countries.
Union Minister Nadda Emphasizes India’s Global Leadership in Healthcare
Addressing the gathering, Union Minister of Health and Family Welfare, Jagat Prakash Nadda, highlighted India’s pivotal role in global healthcare.
He underscored the nation’s achievements during the COVID-19 pandemic, including its rapid expansion of healthcare infrastructure and successful vaccination rollout.
Nadda emphasized the importance of the ICDRA platform in fostering collaboration, knowledge sharing, and developing robust regulatory frameworks.
CDSCO’s Contributions to Global Health
The Central Drugs Standard Control Organization (CDSCO) was lauded for its significant contributions to global health.
Nadda highlighted CDSCO’s role in ensuring the safety, efficacy, and quality of medical products in India and for export to over 200 countries.
He also mentioned the organization’s efforts in digitizing regulatory processes, promoting transparency, and strengthening the medical device industry.
Key Discussions and Regulatory Challenges
The 19th ICDRA featured a series of insightful discussions on pressing global healthcare issues.
Regulatory authorities and industry leaders explored topics such as:
- Smart Regulation: The evolving landscape of regulatory reliance and the World Listed Authorities (WLA) framework.
- Medical Devices: Global and regional regulatory frameworks for medical devices, including In Vitro Diagnostics (IVDs).
- Quality of Pharmaceutical Starting Materials: Ensuring the quality and safety of pharmaceutical products from their inception.
- Artificial Intelligence in Healthcare: The role of AI in improving regulatory oversight, pharmaco-vigilance, and clinical trials.
- Regulatory Preparedness: Lessons learned from the COVID-19 pandemic and the need for future preparedness.
India’s Commitment to Global Health
Nadda reiterated India’s unwavering commitment to advancing global health.
He emphasized the country’s focus on “Skill, Speed, and Scale,” which has enabled it to meet the increasing demand for pharmaceutical products while adhering to global quality standards.
India’s role as a global partner in building a healthier, safer, and more resilient world was reaffirmed.
International Leaders Commend India’s Role
The ICDRA was marked by strong international support.
Dr. Tedros Adhanom Ghebreyesus, Director-General of the WHO, commended India for hosting the event and highlighted the importance of global cooperation in drug regulation.
Dr. Saima Wazed, Regional Director of WHO Southeast Asia Region, emphasized India’s role as a major provider of generic medicines and vaccines.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
QR Code mandatory for all Vaccines in India to check fakes
India’s Vaccine Regulatory System Receives WHO Approval
USFDA declines to approve this drug for low blood sugar in infants
MvPI Releases Updated Medical Device Adverse Event Reporting Form
USFDA inspection concluded at Alembic Pharma with no observation
Govt to amend Drugs Rules to crack down on Fake Documents
USFDA approval granted for generic Cetirizine tablets
Cosmetic Labels: DCC suggests BIS Standards
Govt to Mandate QR Codes on All Anti-Cancer Drugs to Combat Counterfeit Crisis
Need for Regulatory Reforms to improve contraceptive access and workforce participation
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
